Given that the patients investigated in our cohort and TCGA cohort are from different races, thus we speculate that different race backgrounds may lead to some different correlations between CNGs of ErbB family members and clinicopathological characteristics in glioma patients. The gene discussed is EGFR; the disease is central nervous system cancer.